Neo Ivy Capital Management’s First American FAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128K Buy
+1,867
New +$124K 0.03% 295
2023
Q4
$906K Sell
14,052
-42,340
-75% -$2.41M 2.02% 14
2023
Q3
$3.19M Buy
56,392
+30,664
+119% +$1.84M 1.4% 11
2023
Q2
$1.47M Buy
+25,728
New +$1.45M 0.77% 26
2022
Q4
– Sell
-7,589
Closed -$350K – 406
2022
Q3
$350K Buy
7,589
+6,273
+477% +$339K 0.92% 17
2022
Q2
$69K Buy
+1,316
New +$76.6K 0.18% 193
2021
Q3
– Sell
-13,865
Closed -$864K – 519
2021
Q2
$864K Buy
+13,865
New +$882K 0.87% 8
2020
Q4
– Sell
-679
Closed -$34K – 473
2020
Q3
$34K Buy
+679
New +$35.2K 0.03% 388
2020
Q2
– Sell
-29
Closed -$1K – 502
2020
Q1
$1K Sell
29
-11,953
-100% -$683K ﹤0.01% 444
2019
Q4
$699K Buy
+11,982
New +$732K 0.81% 34

Other funds holding FAF

Neo Ivy Capital Management's FAF Position: Q2 2026 in Review

Neo Ivy Capital Management opened a new position in First American (FAF) in Q2 2026: 1,867 shares worth $128K. The stake represents 0.03% of the portfolio and ranks #295 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in FAF as recently as Q4 2023.

Neo Ivy Capital Management first reported a position in FAF in Q4 2019 and has held it in 10 quarters since. The position peaked at $3.19M in Q3 2023. 475 funds tracked by Wall St. Rank hold FAF as of Q2 2026.

  • Neo Ivy Capital Management held 1,867 shares of First American worth $128K as of Q2 2026.
  • First American was a new Neo Ivy Capital Management position in Q2 2026.
  • First American made up 0.03% of Neo Ivy Capital Management's portfolio in Q2 2026, its #295 holding.
  • Neo Ivy Capital Management first reported a position in First American in Q4 2019 and has held it in 10 quarters since.
  • Neo Ivy Capital Management's First American position peaked at $3.19M in Q3 2023.
  • 475 funds tracked by Wall St. Rank held First American as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.